Neil Kumar is the founder of BridgeBio. BridgeBio has raised $349M in total funding. Latest round: IPO. Based in Palo Alto, California.
Neil Kumar is the founder and CEO of BridgeBio, a pioneering biotech company that develops genetically targeted medicines to treat patients with genetic diseases. He has built a new biotech model focused on accelerating drug development for underrepresented genetic conditions.
Full founder directory · Investor directory · Company funding database · Fundraising library